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Abstract 
Since vitamin D deficiency is common at birth, the objective of this study 
was to test if postnatal vitamin D supplementation would normalize bone 
mineralization. Forty guinea pigs were randomized to receive a diet with or 
without vitamin D3 during pregnancy. Newborn pups were randomized to receive 
10 IU of vitamin D3 or a placebo daily until d28. Measurements at birth and d28 
included whole body and regional bone mass, osteocalcin and deoxypyridinoline, 
plus biomechanical testing of excised tibias and femurs. Offspring from deficient 
sows had lower body weight, whole body and tibia bone mineral content (BMC) 
and lower osteocalcin and biomechanical integrity. By d28 this group had lower 
whole body bone density and femur BMC, unless supplemented. Interactions with 
gender showed males continued to have low 25(OH)D despite supplementation. 
Therefore, neonates born to sows with dietary vitamin D deficiency require 
supplemental vitamin D to support normal bone mineral accretion. 
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Resume 
Puisque un deficit de vitamine D est commun a la naissance, l'objectif de 
cette etude etait d'examiner si un supplement de vitamine D post-natale 
normalisera la mineralisation d'os. Quarante cobayes ont ete randomises pour 
recevoir un regime avec ou sans vitamine D3 pendant la grossesse. Des chiots 
nouveau-nes ont ete randomises pour recevoir 10 IU de vitamine D3 ou un 
placebo quotidien jusqu' a jour 28. Les mesures a la naissance et au jour 28 ont 
inclus la masse d'os regionale et du corps entier, l'osteocalcine et la 
deoxypyridinoline, plus l'essai biomecanique des tibias et femurs excises. Les 
chiots des meres insuffisants ont moins du poids corporel, masse osseuse du corps 
entier et du tibia ainsi que, d'osteocalcine et d'integrite biomecanique en 
comparaison au groupe suffisant. A jour 28, ce groupe avait une densite d'os du 
corps entier et de femur plus bas s'ils n'etaient pas supplemented Les interactions 
avec sexe ont montre que les males continue a avoir un niveau bas de 25(OH)D 
malgre la supplement. Done, nouveau-nes, nes des meres avec l'insuffisance 
dietetique de vitamine D ont besoin de la vitamine D supplemental pour 
soutenir leur accroissement normale des mineraux osseuse. 
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1.1 Physiology of Vitamin D 
1.1.1 Function of Vitamin D 
Vitamin D is essential to health and can be acquired through 
endogenous synthesis or exogenous sources (1). Regardless of the source, 
the active form of vitamin D (l,25(OH)2D) is involved in regulating 
calcium and phosphorous concentrations in the blood by promoting their 
absorption from food in the small intestine and by promoting re-absorption 
of calcium from the kidneys. Without vitamin D humans would only be 
able to absorb 10-15% of dietary calcium and approximately 60% of 
phosphorous through passive transport. In the presence of vitamin D 
however, the efficiency of calcium and phosphorous intake is increased 
about 30-40% and 80%, respectively, through active transport processes 
(1). This supports bone formation and mineralization and is required to 
develop and maintain optimal peak bone mass. 
1.1.2 Vitamin D Acquisition 
Vitamin D can be acquired in the diet (typically from milk and 
margarine in Canada) or through endogenous synthesis, which is triggered 
by ultraviolet beta (UVB) radiation from the sun (1-3). There are two 
dietary sterols that can form precursors for vitamin D. One form is found 
in plants and is called ergosterol that can be activated through irradiation 
to form ergocalciferol (also known as vitamin D2 or ercalciol). This 
compound is most commonly sold commercially to prevent or treat rickets 
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and used in some plant beverages such as rice beverage. The other sterol, 
7-dehydroxycholesterol, is mammalian derived typically from sources 
such as fish or liver (see Table 1-1 for selected dietary sources of vitamin 
D). It is found throughout both the dermis and epidermis and when it is 
exposed to a specific wavelength of UVB light (290-315 nm) it forms 
previtamin D3 (precalciferol). Within two to three days precalciferol is 
thermolised to cholecalciferol (vitamin D3) and will diffuse from the skin 
to the blood stream where is it transported to the liver by a-2globulin 
vitamin D-binding protein (1). 
Factors that can affect the endogenous synthesis of vitamin D 
include: 
o Skin pigmentation: melanin competes for UVB photons. 
Therefore the more melanin in the skin, the less UVB 
photons are available for endogenous synthesis of vitamin 
D(4). 
o Wearing sunscreen: an SPF greater than 8 eliminates 
endogenous synthesis (3). 
o The time of year: for example in Canada UVB radiation 
does not adequately reach latitude of 42 ° N between 
October to March/ April to elicit endogenous synthesis of 
vitamin D. Thus during this time there is increased risk for 
vitamin D deficiency. This is in part due to the reduced 
UVB and is attributed to the zenith angle, which is in turn 
3 
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related to the shortening of days during the winter months 
(5). 
o Clothing: Vitamin D synthesis cannot occur if the sunlight 
passes through clothing or windows (3). 
The factors listed above are important to consider since vitamin D 
deficiencies have been detected in pregnant women and children world wide due 
to cultural or religious clothing habits (3), skin pigmentation (4) and also due to 
an increase in sedentary lifestyles that is associated with less exposure to UVB 
(2,6). In addition to reduced endogenous synthesis of vitamin D, dietary intake of 
vitamin D is felt to be inadequate relative to current recommendations and based 
on low vitamin D status year round (4). 
4 
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Table 1-1: Selected Foods Containing Vitamin D 
Food 
Cod liver oil, 1 Tablespoon 
Salmon, cooked, 100 g 
Mackerel, cooked, 100 g 
Tuna fish, canned in oil, 165 g 
Milk, non-fat, reduced fat, and whole, 
vitamin D fortified, 1 cup 
Margarine, fortified, 1 Tablespoon 
Egg, 1 whole (vitamin D is found in 
egg yolk) 
Liver, beef, cooked, 75 g 
Breast milk, human, whole, mature, 1 
Litre 
Breast milk, human (1 Litre) 
International Units (IU) per serving* 
1279 
272 
104 
46 
107 
75 
22 
21 
41.6 
-10-30** 
* Health Canada, Canadian Nutrient File, 2007 
** Ziegler et al (7), mature milk not specified. 
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Regardless of the source of vitamin D, both dietary and 
endogenously acquired forms are only biologically active following 
further metabolism through hydroxylation. The first hydroxylation occurs 
in the liver at the 251 carbon and the subsequent hydroxylation occurs in 
the kidney at the 1st carbon, it is now the metabolically active form 
l,25(OH)2D (8). The circulating serum concentration of 25(OH)D is 
commonly used to indicate vitamin D status as it reflects both dietary and 
endogenous sources. Since the half-life of 25(OH)D is 2-3 weeks it is 
considered to be the most reliable measure of a person's cumulative 
vitamin D status (11). The half-life of the active form of vitamin D, 
l,25(OH)2D3, is only 4-6 hours making it a difficult and unrealistic 
measure of vitamin D status (11). 
1.1.3 Functions of Vitamin D at the Cellular Level 
Vitamin D status continues to be a public health concern due to its 
role in the prevention of rickets, osteomalacia and osteoporosis. It has 
been suggested that the role vitamin D plays may not be limited to the 
regulation of calcium in the body. It may help maintain a healthy immune 
system and help regulate cell growth and differentiation (9). The discovery 
of nuclear vitamin D receptor proteins (VDR) in over 30 tissues 
throughout the body including bone, kidneys, lungs pancreas, brain and 
muscle has lead to this theory. Vitamin D is also proposed as a factor in 
the prevention of various diseases such as cancer, diabetes and multiple 
6 
   
  f
    
th 
 st  
1,25(    
ife  
i  t   t  t li l     '  l ti  
it i   t t  ( ).  lf-life f t  ti  f r  fvit i  , 
1,25( )2 , is only 4-6 hours aking it a difficult and unrealistic 
e as re f ita i   stat s ( ). 
e   
 m 
   
  
  
       tiation .   
n l  it i   t  t i   i    ti  
i  
       ,    
sclerosis (8-11). However its main function is to maintain adequate blood 
calcium levels. This is done through interacting with receptors in the small 
intestine. One, twenty five dihydroxyvitamin D enhances absorption of 
intestinal calcium and dietary phosphorous by increasing the efficiency of 
their absorption (12). If there is inadequate dietary calcium available to 
meet requirements l,25(OH)2D and parathyroid hormone mobilizes 
monocytic stem cells in the bone marrow to become mature osteoclasts. 
Interaction with the VDR in osteoblasts ultimately leads to the dissolving 
of the bone mineral matrix in order to restore blood calcium, signal 
transduction and neuromuscular activity (12).When calcium status is 
adequate, vitamin D also stimulates bone formation by enhancing bone 
matrix synthesis and mineralisation (13). 
1.1.4 Interpreting Vitamin D Status 
The scientific counsel recommendations for vitamin D intake were 
developed by the Institute of Medicine (IOM) of the National Academy of 
Sciences. The Dietary Reference Intake (DRI) value for vitamin D is 
currently an adequate intake (AI) value set at 200 IU/d from birth to 50 
years of age with higher values thereafter (14). 
Most health professionals define vitamin D deficiency as a serum 
25(OH)D level of less then 50 nmol/L however 20 to 37.5 nmol/L is 
considered the lower limit for the normal range (1,15). In infants a vitamin 
D deficiency is defined as a serum 25(OH)D level less than 27.5 nmol/L 
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(15). A serum 25(OH)D level greater than 75-100 nmol/L is preferred in 
adolescents and adults since vitamin D status is inversely related to 
parathyroid hormone levels until this level is reached (1). 
Vitamin D deficiency is a problem in Canada and other countries 
where seasonal sun patterns affect inhabitants ability to endogenously 
synthesize vitamin D. Countries closer to the equator also report vitamin D 
deficiency within their populations that is thought to be due to an increase 
in sedentary lifestyle as well as the religious or cultural requirement to 
remain fully covered (16-19). Vitamin D deficiency is an issue throughout 
the lifespan. In infants it can lead to rickets which is characterized by 
abnormal growth of bones resulting in bowed legs, outward-bowed chest 
and rachitic rosary on the ribs (20). In adults, it manifests as osteomalacia 
with the symptoms include bending of the spine and bowing of the legs. It 
can also lead to muscle weakness and bone pain, which can go unnoticed 
during the initial stages of the deficiency. Long term vitamin D deficiency, 
even that which does not lead to rickets or osteomalacia can over time 
play a role in adult bone loss (21). This reduction in bone mass in older 
persons is known as osteoporosis and is characterized as bones becoming 
porous and fragile (21). 
Vitamin D toxicity is rare and is most likely linked to high intakes 
of supplements or cod liver oil. It is unlikely to occur from intake of food 
or sun exposure. The symptoms of vitamin D toxicity include nausea, 
vomiting, poor appetite, constipation, weakness, weight loss and elevated 
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blood concentrations of calcium that cause mental confusion (12). High 
blood concentrations of calcium also can cause heart rhythm abnormalities 
and eventually calcification of soft tissues such as the renal tubules of 
kidney (14). The tolerable upper limit for vitamin D is currently 1000 IU 
for infants from birth to 12 months of age and 2000 IU thereafter (14). 
1.2 Fetal programming 
There is some evidence that the intrauterine environment does play 
a role in later bone health. Evidence is growing for the theory of fetal 
programming which suggests that the future growth and development of 
the skeleton is influenced by adverse effects in the critical period in utero 
where the greatest amount of growth and development take place (22,23). 
This suggests that what happens in utero has a significant effect on the 
risk of developing chronic diseases as well as future quality of life. Fetal 
programming may influence susceptibility to diseases such as cancer, 
cardiovascular disease, hypertension, diabetes and obesity (23). In 
relation to bone health and vitamin D status, epidemiological studies such 
as the one by Arden et al. (24) have shown that adult women born small 
for gestational age have higher circulating 1,25(OH)2D (24). Thus the 
intra uterine environment may affect adult bone mineral density (BMD). 
Data now suggest that environmental factors, nutrition included, as 
early as in fetal life have longstanding effects on bone mass. Limited intra 
uterine nutriture (i.e. poor placental development leading to growth 
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restriction) is related to lower bone mass in children (25) and elderly men 
(26) plus a higher incidence of hip fracture in men and women (27). 
Evidence indicates that both growth restricted term born infants (low birth 
weight <2500 g) as well as prematurely born infants have longstanding 
high bone turnover causing osteopenia (28,29). Low birth weight is an 
indicator of nutritional status in utero and it is linked to a significant 
(0.86%) increased rate of mortality by age 75 in both men and women 
(30). These individuals are at higher risk of suboptimal peak bone mass 
and long term risk of poor bone health problems including osteopenia 
compounded by osteoporosis and fracture (32). Weight at one year has 
also been shown to have a significant effect on bone mineral content 
(BMC). In a longitudinal study, a higher weight at 1 year of age was 
shown to be associated with increased BMC at the lumbar spine and 
femoral neck at 27 years of age (31). 
In addition, laboratory studies using rats have shown that the 
offspring of pregnant rats deficient in vitamin D have abnormal skeletal 
growth and morphology despite provision of a supplement to the dam 
during lactation (32,33). It is possible that if the supplement had been 
given directly to the pups instead of through mothers' milk the supplement 
would have yielded better recovery. Alternatively, it is possible that there 
is a lifelong negative effect of vitamin D deficiency in utero on subsequent 
bone mass. 
Experimentally controlled studies in animals support these 
10 
 I
 
  i
ort   
 
       
  t r i   fr t r  ( ). i t t  r  
ls   s  t    si ifi t ff t   i r I t t 
( ). I   l it i l t ,  i r i t t  year of age was 
s  t   ss i t  it  i r s   t t  l r s i   
fe oral neck at 27 years f age (31). 
i   t 
   
  
t  '
    
 t    
 . 
I
descriptive human studies. For example, the small sized rat pup at birth 
that is fed a regular diet thereafter, has compromised bone mass in 
adulthood (22). Such observation suggests that bone mass does not fully 
recover after early life insult despite optimal nutrition and that bone mass 
can be programmed by early life nutritional insult. 
In contrast, better nourishment as indicated by higher yet normal 
birth weight (34) is associated with higher adult whole body, lumbar and 
hip bone mass. This association holds true even after accounting for age, 
sex and height plus adult behavioural factors including smoking, alcohol, 
dietary calcium and exercise (34). A number of factors are known to 
affect human infant bone mass at birth including vitamin D status of 
mother and infant (35), maternal calcium intake (36), activity (37), and 
smoking (37) while pregnant. At birth, infants with higher vitamin D 
status have higher weight adjusted bone mass (35). Longitudinal studies 
reveal that maternal intake of fat, phosphorous (38) and smoking (39) 
while pregnant are linked with the child's subsequent reduced bone mass 
at 8 years of age. In one study, maternal consumption of milk while 
pregnant accounted for 35% of the variation in femoral neck BMD in the 
children at 8 years of age (38). This study was conducted in Australia 
where milk is not fortified with vitamin D. The authors did not indicate if 
the milk was full fat or otherwise and thus the contribution of naturally 
occurring vitamin D to this association is not clear. However, maternal 
vitamin D status in pregnancy and thus fetal exposure in utero is related to 
11 
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the ilk as full fat or other ise and thus the contribution of naturally 
occurring vita in D to this association is not clear. However, aternaI 
vita in  status in pregnancy and thus fetal exposure in utero is related to 
Il
bone mass in children (40). Of those studied by Javaid et al. (40) 31% of 
the mothers had low circulating levels of vitamin D during late pregnancy. 
This resulted in lower whole body and lumbar spine BMD in their children 
at the age of 9. 
Not only does the mother's status during pregnancy play a role in 
the bone development of the child, but the child's status during infancy 
will play a role as well. Infants who are vitamin D deficient with a 
deficiency being defined as less then 27.5 nmol per litre 25(OH)D had an 
8.5% reduction in their whole body BMC when it was corrected for body 
weight. Of the infants studied 36% were defined as vitamin D deficient; 
46% of their mothers were also reported to be deficient as well (35). These 
same infants were studied at 6 months of age to determine if the season in 
which they were born had an effect on their bone development. As 
mentioned earlier season can affect vitamin D synthesis. It was found that 
the vitamin D status of the infants varied by season and when tracked 
showed changes in bone mineral accretion of the lumbar spine by 6 
months of age. The infants born in the winter and spring had lower bone 
mineral accretion than the infants born in the summer or fall (41). This is 
significant since those with lower accretion are at an increased risk for 
spinal fracture later in life. 
In a randomized controlled trial of vitamin D supplementation of 
breast-fed infants compared to placebo, radial BMC was transiently 
elevated after 3 months of supplementation when compared to infants who 
12 
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did not receive a 400 IU/day supplement of vitamin D (42). In a 
prospective cohort study, providing a vitamin D supplement in infancy 
(median duration of 12 months) had a longstanding association with 
higher BMD at 7 to 9 years of age (43). The distal radius was 6% higher 
and the femoral neck 9% higher in the girls who received a vitamin D 
supplement in infancy (43). These are common sites for osteoporotic 
fracture later in life (44). Thus there is some evidence that maternal 
vitamin D status and higher intake of foods containing vitamin D is 
associated with higher bone mass in infants and subsequently in 
childhood. 
Conversely, if vitamin D deficiency is not corrected, the 
consequences are not clear. It is also not clear how much vitamin D is 
required in infancy for optimal outcomes. Longitudinal studies that link 
vitamin D status at birth, subsequent dietary vitamin D intake from foods 
and supplements with peak bone mass and maintenance with aging are not 
available. The most realistic area to target is to improve vitamin D status 
of the mother to prevent deficiency from the outset. Yet, it seems that 
there is not enough evidence to suggest that maternal deficiency of 
vitamin D has any longstanding consequences to the offspring's bone 
health. Human studies both descriptive and randomised clinical trials 
might be compromised by the issue of confounding variables. 
Nonetheless, similar results are observed in animal studies where these 
variables are highly controlled. 
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The mechanism in which young animals acquire vitamin D was 
investigated using the rat model of intrauterine transfer and fetal storage of 
vitamin D (45). By providing an injection of 3H or 14C labelled vitamin D3 
to deficient rats prior to mating accumulation of the labelled vitamin D in 
the pup's tissue could be followed throughout their gestation and lactation 
periods (45). This was the first indication of how and where mammals 
transfer and store vitamin D in fetal tissue. It was concluded that primary 
transfer of vitamin D from the dams to the pups occurred during the third 
trimester of gestation while in utero and not after birth during the lactation 
period (45). This is the same period in which fetal mineralization occurs 
(46). The guinea pig model of vitamin D deficiency was used to 
investigate the effects of an intra uterine deficiency of vitamin D on fetal 
mineralisation (46). A deficiency at this stage of development led to low 
or undetectable 25(OH)D3 and l,25(OH)2D3 and a 10-15% lower body 
weight and whole body BMC by day 57 of gestation (46). 
1.3 Vitamin D Nutrition in Women and Children 
1.3.1 Vitamin D Status in Canada 
Human studies show vitamin D deficiency exists in mothers and 
infants both in Canada (35,47-49) and worldwide (17,18,50-52). To 
highlight the severity of vitamin D deficiency in Canada, Rucker et al (53) 
reported that 34 % of women (27-89 years) living in Calgary had low 
vitamin D status in at least one season. Vieth et al (49) report on women 
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living in the Toronto region and observed the prevalence of vitamin D 
deficiency to be 14.8 % in white women and 25.6 % in non-white non-
black women. During the winter months, the prevalence was not 
significantly affected by dietary or supplemental vitamin D intakes at 
values similar to the AI of 200 IU/d (5 ]ug/d) (14,49,54). Recently, Weiler 
et al. report that 46 % of healthy women are deficient in vitamin D 
immediately postpartum and that 35% of their newborn infants were 
deficient in vitamin D (35). All of these studies have been conducted at 
major Canadian cities that are located at a latitude greater than or equal to 
43 °N; for example Toronto is 43 °N, Winnipeg ~49°N, and Calgary 
~50°N. The high rate of deficiency is not surprising since cutaneous 
synthesis of vitamin D in these regions is thought to be limited to April 
through September (55). Thus many Canadians at risk for vitamin D 
deficiency and the consequence includes potentially limited bone mass or 
altered bone metabolism. Ward et al. (48) highlighted that not only is 
vitamin D deficiency an issue for infants, but that amongst Canadian 
children vitamin D deficient rickets is still present. An annual incidence 
rate of 2.9 cases of rickets per 100 000 children per year was documented 
between July 1, 2002 and June 30, 2004. The mean age of the children 
diagnosed with rickets was 1.4 years of age (48). Many of these infants 
were of First Nations status and were not receiving vitamin D 
supplements. For pregnant First Nations women vitamin D deficiency 
seems common, possibly due to the predominance of residence in more 
15 
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~50oN. The high rate of deficiency is not surprising since cutaneous 
synthesis of vitamin D in these regions is thought to be limited to April 
through September (55). Thus many Canadians at risk for vitamin D 
deficiency and the consequence includes potentially limited bone mass or 
altered bone metabolism. Ward et al. (48) highlighted that not only is 
vitamin D deficiency an issue for infants, but that amongst Canadian 
children vitamin D deficient rickets is still present. An annual incidence 
rate of 2.9 cases of rickets per 100 000 children per year was documented 
between July 1,2002 and June 30, 2004. The mean age of the children 
diagnosed with rickets was 1.4 years of age (48). Many ofthese infants 
were of First Nations status and were not receiving vitamin D 
supplements. For pregnant First Nations women vitamin D deficiency 
seems common, possibly due to the predominance of residence in more 
 
extreme northern latitudes for those participating in existing reports, 
darker skin pigmentation and low dietary intake. Lebrun et al (56) 
reported that 76 % of Northern Manitoban women had 25(OH)D in the 
deficient range. Waiters et al (57) reported upon vitamin D status of 
women living in the Inuvik zone of the former Northwest Territories and 
vitamin D status. A predicted prevalence of deficiency was estimated at 
48.4 % in First Nations mothers taking a vitamin D supplement and 88.6 
% in those not consuming a supplement. For non-First Nations mothers 
taking a supplement the prediction was 15.1 % and without a supplement 
63.5 %. Most maternal supplements contain 100 to 200 IU of vitamin D3. 
Thus if the studies by Vieth et al (58) and Lebrun et al (56) Waiters et al 
(57) are reflective of the Canadian population of women of child bearing 
years, deficiency is likely very common, ranging from 15 % to 89 % of the 
population. 
1.3.2 Vitamin D Status World Wide 
Vitamin D deficiency is not only an issue in Canada, but 
worldwide. Summer born infants in Japan have higher vitamin D levels as 
measured by 25(OH)D status than winter born infants (47.3 ± 2.1 nmol/L 
vs. 22 ± 8.5 nmol/L) (59). Vitamin D is related to exposure to UVB 
radiation so the mothers of the summer born infants were either exposed to 
enough radiation to stimulate endogenous synthesis or had access to 
seasonally available vitamin D rich foods. It was found that 10% of breast-
16 
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fed infants living in Iowa were vitamin D deficient at 280 days of age 
(25(OH)D < 27.5 nmol/L). Vitamin D deficiency was greatly associated 
with winter, dark skin, and lack of supplementation. Of the breast-fed 
infants sampled in the winter the majority (78%) of them were vitamin D 
deficient (7). 
Nehama et al (60) compared spring born infants to autumn born 
infants in Israel and it was concluded that spring born infants had a 46.5% 
lower 25 (OH)D status than those born in the autumn (28.3 ± 2.5 nmol/L 
vs. 45.3 ±3.3 nmol/L). Namgung et al. found no difference in 25(OH)D 
status in relation to season in infants born in Ohio (summer: 60.5 ±3.3 
nmol/L vs. winter 54 ± 6.8 nmol/L) (61), however there was a difference 
noted in infants born in the summer versus the winter in Korea (30 ± 1.5 
nmol/L vs. 10.8 ± 7.5) (62). 
1.4 Assessment of Bone 
To assess bone, many qualities need to be measured, some of 
which are not feasible to study in humans. Methods of evaluating bone 
include: bone densitometry, evaluation of biochemical markers of bone as 
well as biomechanical testing. Dual-energy x-ray absorptiometry (DXA) is 
the established standard for measuring BMD and is the most frequently 
used quantitative radiologic method to assess bone mass (12). It has been 
utilized successfully to measure BMC, BMD and bone area in adults, 
children and infants. It is most commonly performed on the spine, hip, 
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legs and arms since these are areas at risk of fracture (12). The advantage 
of DXA is that it is a quick and painless procedure which can be used to 
track losses and gains in BMD (12). 
DXA has been validated for use in animal models including the 
guinea pig model, where both whole body and regional scans have been 
performed successfully (46,63). Although DXA is used as a substitute for 
testing bone fragility, biomechanical testing offers a clearer picture of the 
structural quality of the bone. 
In basic animal studies biomechanical testing can be performed using a 
materials testing machine. Tests such as compression tests have been used to 
evaluate the ability of the spine to withstand a force and flexure tests (also known 
as three-point bending tests) have been used to determine the strength of long 
bones such as the tibia and femur. There are standards and recommendations to 
follow when conducting bone strength testing. Storage condition, storage and 
testing temperature, force and speed of the materials testing machine can alter the 
results (64-66). Some key terms in understanding biomechanics are stress which 
is the force per unit area or the force put on an area of bone, strain which is the 
percentage of change in length or relative deformation of the bone and the 
Young's modulus that is a measure of the elasticity (versus rigidity) of a bone in 
relationship to stress and strain (65). Other key terms include load which is the 
amount of force applied to the bone (67). Yield which is when the stress at which 
a marked increase in deformation occurs without an increase in load (67). A 
flexure test is when a specimen is supported on two beams and a load is applied to 
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the center (65). Stress and strain are calculated from incremental increases in load. 
Results are plotted on a stress strain curve where the maximum stress at failure is 
the flexure strength. Flexure extension is the term used to describe the amount the 
specimen moves during the application of the load during the flexure test (65). 
Biochemical markers are effective tools used to assess bone 
formation or resorption. Markers of bone formation can be either direct or 
indirect products of osteoblast activity (68). Serum osteocalcin is directly 
related to osteoblast activity and is highest when bone formation is at its 
greatest such as during infancy (68). Human infants with low vitamin D 
levels also have low osteocalcin levels (69). Markers of bone resorption 
such as deoxypyridinoline (DPD) are degradation products of type I 
collagen cross-links in bone (68). Concentrations of DPD are expected to 
be low during periods of rapid bone growth (68). Young men born with 
low birth weight were found to have an increase in both osteocalcin and 
DPD (70). It was concluded that this biochemical combination represented 
accelerated bone turnover, but also a hormonal equilibrium in these young 
men (70). 
1.5 Animal Models of Bone Development and Vitamin D Deficiency 
1.5.1 Selecting the Appropriate Model 
Animal studies present a reproducible ethically sound model in 
which to investigate the effects of vitamin D deficiency on bone growth, 
development and strength over both the short and long term. Finding the 
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appropriate model for the condition to be studied allows for a stronger 
translation of results to human health. With animal models, there is the 
opportunity to explore the effects of nutrient deficiencies as well as to 
provide an intervention dose of a particular substance. Animal models 
provide the advantage of studying the effects of a treatment in a shorter 
more controlled period of time compared to studies performed with human 
subjects. Some commonly used animal models in the study of bone growth 
and development are the mouse, rat, sheep and guinea pig (33,46,71,72). 
These models all have their advantages and disadvantages. 
The animal model most frequently used in the study of bone mass 
and osteoporosis is the rodent. With the creation of knock out models, the 
mouse has become a valuable tool in the study vitamin D deficiency. Both 
the rat and mouse develop osteoporosis in response to dietary 
manipulation as well as ovariectomy. For example Karabelos et al. studied 
the effects of a single dose of 2000 IU of vitamin D3 on bone 
mineralization in neonatal rats (26). The large bolus dose resulted in 
reduced whole body weight, BMC and BMD at 3.5 months of age 
compared to the vehicle injection when given to the rats within 24 hours 
after birth (33). This suggests that providing supplemental vitamin D in 
small daily doses may be the better strategy in which to recover and 
optimise vitamin D status while preventing the negative outcomes 
associated with the single large dose. 
The rat model has been used to investigate the specific intra 
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uterine transfer and vitamin D storage in fetal tissue (45). Vitamin D 
deficient female rats were given an injection of H or 14C tagged vitamin 
D3 before mating. Dams and pups were then culled at various stages 
during the pregnancy and lactation period in order to determine the main 
source of the pups' vitamin D stores. They concluded that the main supply 
of vitamin D for the pups was provided in utero by the dam. The number 
of vitamin D molecules in the pups rapidly increased during the last third 
of gestation going from 0.36 pmol/fetus on day 14 of gestation to 62.2 
pmol/fetus at birth. This was the first article to indicate that in rodent 
mammals vitamin D is accumulated by the fetus during the end of the 
third trimester (45). 
The effects of vitamin D deficiency on pregnant and lactating rats 
and their pups was also studied by Cancela et al. (71). Vitamin D deficient 
rats were mated and followed throughout pregnancy and lactation. 
Postpartum a supplement of 10 IU of vitamin D was given per day to the 
lactating rats. The 25(OH)D levels of the dams and pups in the both the 
deficient dams and pups was not detectable. Bone growth was suppressed 
in the vitamin D deficient animals and both the deficient mothers and pups 
exhibited severe signs of osteomalacia. Despite normalized 25(OH)D 
vitamin D status after maternal supplementation, it was found that 
although the vitamin D supplementation reversed the mineral, hormonal 
and skeletal abnormalities caused by the deficiency in the mother, these 
were not corrected in the pups by weaning age (71). Perhaps if the 
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supplement had been provided to the pups versus the mother, the pups 
may have had a better recovery. 
As evident from the research presented above the rat is a popular animal to 
use in the study of bone mass and osteoporosis. This is because of its short 
gestation time, and its ability to have many offspring. This is advantageous for 
studying the effects on a treatment on mammals in utero and throughout 
development (68). Rats are also large enough to perform DXA at the end of their 
suckling period. However, while both the mouse and rat lend themselves nicely to 
long-term studies, measurement of vitamin D status at birth is limited due to small 
blood volume (68). Measurement of bone mass at birth is not feasible in the rat 
since the skeleton does not mineralize until the first week of life, unlike human 
fetuses which mineralize during the third trimester (60). 
Maternal vitamin D deficiency has been shown to disrupt fetal growth and 
mineralization in humans (24), however development has been shown to be 
normal in fetal rats with vitamin D deficient mothers and vitamin D receptor 
gene-ablated mice (46). The use of rats and other small rodents has been criticized 
since they are chemically and functionally immature at birth and are born in large 
litters. Their greatest period of bone growth and formation occurs during the 
suckling and post-weaning period (46). 
Unlike the rat, the guinea pig has a relatively long gestation period (65-72 
days) after which their young are born chemically and physiologically mature. 
They also give birth to a small number of fetuses (on average 2-5) with the 
greatest period of bone growth and development occurring in utero. This starts 
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with ossification centers appearing in the clavicle, face and skull at day 26 of 
gestation and by day 33 of gestation development of the occipital and innominate 
bones (73). 
In guinea pigs the changes measured in osteocalcin during pregnancy 
reflect those described in human pregnancies in which maternal osteocalcin 
remains low throughout pregnancy. Unlike humans and guinea pigs, osteocalcin 
concentrations in the rat peak at day 17 of neonatal life and even during fetal life 
the osteocalcin levels of the rat pup increase with increasing vitamin D levels 
(74). The whole body calcium content of the guinea pig at term is 11.31-14.29 
g/kg fat free mass. This is only slightly higher than a human fetus which 
accumulates 9.55 g/kg free fat mass. Rodents such as the mouse and rat have 
much lower calcium content at the end of gestation (3.43 g/kg and 3.06 g/kg 
respectively) (74). 
Models that are chemically and physiologically mature at birth provide the 
means in which to study the effects of nutrient deficiency in utero on fetal 
mineralization. Bovine and ovine models have been considered since like human 
fetuses, both have high serum osteocalcin at birth. They however have a different 
placental structure which affects the transfer mechanism of calcium and vitamin 
D due to the structural differences as well as the cost of maintaining such a model 
are draw backs (74). In ovine fetuses l,25(OH)2D both total and free are higher in 
the infant than the mother. Differences in trans placental passage and regulation 
of the calcium/phosphate and the calciotropic hormone (i.e. vitamin D) levels are 
higher in the fetus then in the mother. This is opposite to human pregnancies (74). 
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Ovine fetuses like the rat are born chemically and physiologically immature when 
compared to human infants. Due to the similarities in the placenta the guinea pig 
has become a popular model for transplacental calcium transport (74). The fat 
content of both fetal rats and sheep are extremely low (approximately 2%) 
whereas the fetal guinea pig's 11% fat content most closely resembles the human 
infants 16% body fat (72,75). 
1.5.2 The Guinea Pig Model of Maternal Vitamin D Deficiency 
Overall the guinea pig is a model that is much more suitable to study the 
effects of maternal vitamin D deficiency on bone as relevant to human health than 
the rodent ovine or bovine models. Data obtained from fetal guinea pigs in 
relation to bone markers and mineralization have been shown to be comparable 
with those of human fetuses (46,73-76). The guinea pig model has been validated 
as an appropriate model to study bone development and vitamin D deficiency 
(46,74). The maternal and fetal l,25(OH) D3 and osteocalcin levels respond in 
parallel to that of humans, with higher osteocalcin levels in the fetal guinea pigs 
than in the adults. Maternal and fetal vitamin D levels were comparable to levels 
found in humans and just like rats and humans fetal vitamin D is correlated to 
maternal vitamin D (fetal vitamin D being approximately 20% lower than 
maternal vitamin D) (74). This is because maternal transport through the placenta 
is the main source of fetal vitamin D. 
As outlined in Table 1-2, the guinea pig is larger at birth and thus 
will permit assessment of vitamin D status and bone mass at birth and 
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thereafter. The fetal guinea pig also responds to vitamin D deficiency with 
low BMC and serum 25(OHD) like humans (40,46). This is exemplified in 
a study by Rummens et al. which reported that pregnant guinea pigs 
deprived of vitamin D produce offspring with low whole body bone mass 
measured as BMC (60). Deprivation of vitamin D beginning the first day 
after conception and continuing throughout pregnancy resulted in 
25(OH)D concentrations <10 nmol/L compared to values well over 100 
rtmol/L in the control group. At c-section on day 56 of the typical 68 to 72 
pregnancy, the vitamin D deficient fetuses had low to undetectable 
vitamin D as well as their body weight and BMC were 10-15 % lower then 
the control group (46). Unfortunately the offspring were not followed past 
delivery as they were prematurely born. To date, no study has examined if 
the intrauterine consequences of vitamin D deficiency lead to 
compromised bone mass by normal term delivery and thereafter in the 
guinea pig model. 
25 
 
i  
. 
  i  
. vit
 
I
n   
t 
I  
. t l  i  
m  
vit  
t r 
 
Table 1-2: Comparison of Reproduction, Maturation and Bone Mass 
Characteristics of Humans, Rats and Guinea Pigs 
Length of 
gestation 
Typical 
#fetus/gestation 
Evidence of 
fetal 
ossification 
Size at birth 
Preferred 
nursing period 
Whole body 
BMC at birth 
using DXA 
Age at peak 
bone mass 
Age at which 
bone begins to 
decline 
Human1 
38-42 wk 
1 
Yes 
3.4 kg 
~ 6-12 mo 
74 g[20-22 
g/kg body 
weight] 
25-39 y4 
39+y4 
Sprague Dawley Rat 
20-22 d 
8-12 
No 
5-8 g 
21 d 
Not possible 
4-6 mo5 
9-12 mo6 
-4 
Guinea Pig 
65-72 d 
2-5 
Yes 
75-95 g 
21 d 
1.5 g at gestation d 
57 by c-section 
[-25 g/kg body 
weight]7 
Not reported. 
Not reported 
1
 Information on birth weight and BMC from Weiler et al. (35). 
information related to rat or guinea pig gestation and other general 
characteristics is from the Canadian Council on Animal Care (78) unless 
citation provided. 
3
 Multi or tri-colored or non-inbred/out bread Hartley strains used vs other 
strains such as the inbred Hartley strain that develop osteoarthritis and are 
not appropriate for long-term study. 
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 Tenenhouse et al. (77). 
5
 Peterson et al. (79). 
6Wangetal. (80). 
7
 Rummens et al. (46). 
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2.1 Rationale 
Worldwide, vitamin D deficiency is reported in pregnant women 
and infants. The maternal diet has a powerful effect on the growth, and 
development of the fetus (23). It is unclear, however, if a vitamin D 
deficiency at a critical period of development, such as fetal life, 
permanently alters bone mass and metabolism, even after successful 
reversal of the deficiency. This is not easily studied in a prospective 
manner in humans since 40 years would be required to assess attainment 
of peak bone mass (12). The guinea pig is a unique animal model to 
address these questions since it mineralizes in utero as do humans and in 
contrast to the mouse or rat that mineralize bone postnatally. Additionally, 
the guinea pig is a proven model of dietary vitamin D deficiency with 
associated reductions in bone mass in 3 trimester fetuses obtained by c-
section (46). Recovery of bone mass and vitamin D status following 
vitamin D supplementation postpartum to weaning age has not been 
investigated using this model. This is the topic of this thesis. 
2.2 Objectives and Hypotheses 
The specific objectives of this research using the guinea pig model of 
maternal deprivation of vitamin D during pregnancy are to determine if: 
1. Maternal dietary vitamin D deficiency throughout pregnancy alters 
bone mass in the offspring after spontaneous term birth; 
2. Postnatal neonatal vitamin D supplementation corrects the vitamin 
D deficiency that was acquired in utero and does the supplement 
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alter bone mass by weaning age; and 
3. Altered bone mass attributed to vitamin D deficiency is 
accompanied by altered bone strength at birth and weaning. 
Hypotheses 
It is hypothesized that offspring born to vitamin D deficient mothers will: 
1. Have lower vitamin D status at birth and require post natal 
vitamin D supplementation to normalize vitamin D stores. 
2. Have decreased bone mass and strength unless vitamin D 
supplementation is provided. 
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3.1 Abstract 
While vitamin D deficiency is common at birth, the consequences to 
growth and bone mass by weaning are unclear. This study was designed to 
determine if maternal dietary vitamin D deficiency in pregnancy has a negative 
impact on bone mass of full term neonates and if postnatal supplementation would 
recover the limited bone mass. Forty guinea pigs were randomized to receive a 
diet with or without vitamin D3 during pregnancy. At birth, their offspring were 
randomized to receive 10 IU of vitamin D3 or a placebo daily until d28. 
Measurements at birth and d28 included whole body and regional bone mass, 
osteocalcin and deoxypyridinoline, plus biomechanical testing of excised tibias 
and femurs. Main and interaction effects were detected using factorial ANOVA 
and post-hoc testing using Bonferroni tests. Offspring from deficient mothers had 
lower body weight, whole body and tibia bone mineral content (BMC) and lower 
osteocalcin and biomechanical integrity. By d28 this group had lower whole 
body bone density and femur BMC, unless supplemented. Interactions with 
gender showed males continued to have low 25(OH)D despite supplementation. 
In summary, postnatal vitamin D supplementation normalized neonatal bone 
following maternal dietary vitamin D deficiency, but does not lead to optimal 
vitamin D status in the guinea pig. 
33 
.   
il  it i   i i  i   t i t , t   t  
t      i   l . i  t   i  t  
t i  i  t I i t  it i   i i  i     ti  
i t   ss f f ll t r  t s  if st t l s l t ti  l  
 t  li it   . t Y i  i   i  t  i   
i t it  r it t it i  3 ri  r . t irt , t ir ffs ri g r  
i  t  i   l  vit i  3   l  il  til . 
t  t i t    i l  l    i l  , 
t l i   i i li , l  i i l t ti   i  ti i  
 . i   i t ti  ts  t t  i  t i l  
 st-  t sti  si  f rr i t sts. ffs ri g fr  fi i t t rs  
l   i t, l    ti i   i I t t   l  
t l i   i i l i t it .   t i    l  l  
     ,  .   
         . 
i   
 I   
 
 
3.2 Introduction 
The maternal diet has a powerful effect on the growth and development of 
the fetus (23). The vitamin D status of newborns has a direct correlation to 
maternal vitamin D status (74). In addition, vitamin D deficiency has been 
reported in many countries and cultures around the world in pregnant women and 
newborn infants (17,18,35,50-52). While vitamin D deficiency can be reversed in 
human infants through supplementation, it is unclear if deficiency in utero and 
early in infancy manifests as prolonged altered bone mass and metabolism. It has 
been suggested that the intrauterine environment may play a role in later bone 
health since low circulating levels of vitamin D during late pregnancy associate 
with lower whole body and lumbar spine bone mineral density (BMD) in children 
at the age of 9 years (40). The greatest amount of growth and development occur 
in utero and during the first year of life. Interestingly, vitamin D intake in the 
first year of life is also positively associated with higher bone mass in prepubertal 
girls (81). The difficulty in many of these human studies is that they are not 
controlled trials and thus the true effects of vitamin D status on bone are possibly 
confounded by other fetal and neonatal exposures. 
Studies using animals as models of human systems present a reproducible 
controlled model in which to investigate the effects of deficiency on bone growth, 
development and strength. The animal models most frequently used in the study 
of bone mass are rodents. However, in both the mouse and rat measurement of 
vitamin D status at birth is limited due to small blood volume. Measurement of 
bone mass at birth is not feasible in rodents since the skeleton does not mineralize 
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until the first week of life, unlike human fetuses that mineralize during the third 
trimester (12,46,72). In one study, supplementation of vitamin D was provided to 
lactating rats who had been deprived of vitamin D throughout pregnancy with the 
goal of correcting vitamin D deficiency in pups. Even with supplemental vitamin 
D provided to the mother during lactation osteomalacia and secondary 
hyperparathyroidism developed in the pups 20d post partum (71). In another 
study using rats vitamin D was not required for placental transfer of calcium or 
phosphorus to the fetus, but becomes important to bone formation after birth (32). 
The relevance of these rodent studies to fetal bone mineralization is 
questionable because of their large litters chemical and physiological immaturity 
at birth (73,74,76). Additionally, bone development is normal in fetal rats with 
vitamin D deficient mothers and vitamin D receptor gene-ablated mice (32) 
whereas in humans maternal vitamin D deficiency disrupts fetal growth and 
mineralization (24,35,46). The guinea pig is a non-rodent model validated to 
study neonatal bone development, bone mass and vitamin D status birth (46). The 
guinea pig is larger at birth than mice or rats and will thus permit assessment of 
vitamin D status and bone mass at birth and thereafter. Lastly, at birth, the guinea 
pig has a similar amount of mineral/kg body weight as does the human infant 
(72,75). Like human infants, the fetal guinea pig responds to vitamin D 
deficiency with reduced serum 25(OH)D and BMD (46,82), and is therefore 
hypothesised to require a vitamin D supplement postnatally. 
Therefore, the objective of this study was through using the guinea 
pig model to determine if maternal dietary vitamin D deficiency in 
35 
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pregnancy has a negative impact on fetal bone mineralization and if 
postnatal supplementation in offspring would recover the limited bone 
mass by weaning age. 
3.3 Methods 
Animal Husbandry 
Prior to conduct of the study, ethical approval was obtained from 
the McGill University Animal Care Committee (Appendix A). All 
procedures were conducted in accordance with the guidelines of the 
Canadian Council on Animal Care (78). 
Pigmented (28 day old) guinea pigs (40 female and 10 males; 4:1 
breeding ratio) were purchased from Elm Hill Laboratories (Boston, 
Massachusetts, USA) to form the breeding colony. The room temperature 
was maintained at 21 °C, with the lighting cycle from 0630 to 1830 h and 
was free of UVB exposure to prevent endogenous synthesis of vitamin D. 
At 3 months of age, guinea pigs were randomized to their treatment 
groups and then bred. 
Upon presence of the vaginal plug, the sows were provided a 
vitamin D deficient (deficient group) or sufficient (control group) pelleted 
diet for the full gestation and lactation period and were given food and 
deionized water ad libitum. This approach was taken since it yields 
deficiency during the last trimester when fetal mineralization occurs (46). 
Sows were housed singly in cages with their offspring to 28 days 
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postpartum. At birth, the pups were randomized within litters to receive a 
vitamin D supplement (supplement group) or placebo (placebo group) 
beginning at birth and continuing to d28 of age (i.e. 1 pup per litter 
receiving either the vitamin D supplement or placebo). Any litters with 
more than 2 pups were culled to 2 per litter at either birth or d28, which 
was determined through randomization. Culled pups were used for bone 
strength testing. At 28 days of age, the pups were separated from the sow 
and housed in same sex pairs for a longitudinal study, to be reported 
elsewhere. Growth (body weight g and body length cm) was measured in 
pups at birth and d28. 
Diet 
All diets were in pellet form, isoenergetic, equal in minerals and 
with all nutrients except vitamin D at recommended amounts as per the 
National Research Council and purchased from TestDiet (TestDiet", 
Division of Land O 'Lakes Purina Feed, LLC, Richmond, IN, USA). The 
standard diet contains 1.2 IU of vitamin D3/g diet and is made with 
identical ingredients and manufacturing as the vitamin D deficient diet 
with exception of addition of vitamin D. See Table 3-1 for the diet 
composition. The diets were blinded and the sows were allocated to the 
test diet at random. The diet was stored at -4°C and food intake was 
monitored every two days. 
Vitamin D Supplementation 
At birth pups were randomized to receive either a supplement 
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containing 10 IU of vitamin D3 or a placebo (control) of equal volume. 
Vitamin D supplements and placebo for offspring were provided in-kind 
by Euro-Pharm International (Montreal, QC, Canada) and were prepared 
via the same preparation method as human studies only in a lower vitamin 
D concentration (10 IU/ml versus 40 IU/ml). The dosage of 10 IU or a 
placebo was delivered by orally syringe daily until d28 of life. A daily 
supplement is preferred vs. one large bolus dosage at birth since a 0.05 mg 
(50 |ag or 2000 IU) within 24 hr of birth in rats resulted in reduced whole 
body weight, bone mineral content (BMC) and bone mineral density BMD 
at 3.5 months of age compared to the vehicle injection (83). Diets and 
supplements were blinded using letter coding and only upon completion of 
measurements were the study groups un-blinded. 
Blood Sampling 
Blood was taken from the saphenous vein between 0800 and 1000 
h for all samplings in sows or pups. In sows, sampling took place at 
conception then day 42 (beginning of 3rd trimester) of pregnancy and 
immediately postpartum for measurement of 25(OH)D only. Blood was 
sampled from pups within 48 h of birth and at d28. All samples were 
centrifuged at 3000 g for 30 min to obtain serum and plasma and stored at 
-80°C thereafter to ensure the biomarkers of bone metabolism were stable 
(84-86). 
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Table 3-1: Vitamin D Deficient Guinea Pig Diet Test Diet 
Ingredients 
Sucrose 
Corn Starch 
Soy Protein Isolate 
Powdered Cellulose 
Soybean Oil 
Casein - Vitamin Free 
Dicalcium Phosphate 
Potassium Citrate, Tribasic 
Monohydrate Calcium Carbonate 
Potassium Carbonate 
Salt 
Choline Chloride 
Ascorbic Acid 
Magnesium Oxide 
Vitamin and Mineral Premix 
Vitamin K Premix 
L-Methionine 
Ethoxyquin (a preservative) 
% 
29.4009 
21.8000 
16.7171 
14.0000 
6.0000 
5.0000 
2.6434 
1.1323 
1.1263 
0.6799 
0.5908 
0.2643 
0.2335 
0.1468 
0.1468 
0.0628 
0.0539 
0.0012 
NOTE: the control diet (diet containing vitamin D) has 1.2 IU vitamin 
D3/g diet. 
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Whole Body and Regional Bone Analysis 
At birth and d28, the pups weight and body length from nose to anus were 
recorded. Bone mass was measured using dual-energy x-ray absorptiometry 
(DXA). Anaesthesia was induced using AErrane isoflurane gas (Baxter Inc., 
Mississauga, ON, Canada) at 5% in an induction chamber followed by 
maintenance at 2% delivered using a cone mask. Isoflurane gas has been 
successfully used in guinea pigs as anaesthesia prior to measurement of bone 
mass (87). The guinea pigs were measured prone with limbs extended and 
scanned in whole body and high-resolution modes using a Discovery Series 
4500A densitometer (Hologic Inc., Bedford MA, USA), and the small animal 
software. Whole body, lumbar spine 1-4, femur and tibia were measured for bone 
area, BMC and BMD. Daily calibrations of the machine were performed using a 
spine phantom; the coefficient of variation with the phantom was 0.53% ± 
0.01g/cm2 for BMD, 0.66% ± 0.37g for BMC and 0.43% ± 0.23 cm2 for area. 
DXA was also performed on the excised femurs of the culled animals in order to 
obtain BMC, BMD and area measurements ex vivo for comparison among groups 
with standardized positioning. Both right and left tibias and femurs were placed in 
the anterior to posterior direction and scanned separately. Bones were submersed 
in a water bath to imitate soft tissue. The coefficient of variation of three 
consecutive measurements was 5.3% for whole body BMC, 1.9% for spine BMC, 
2.3% for tibia BMC and 0.9% for femoral BMC. 
Tissue Sampling 
Guinea pig litters were culled to two using randomization to 
necropsy at either birth or d28 after completion of the DXA. They were 
40 
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anesthetized, which was induced and maintained at 5%. Blood was 
sampled using cardiac puncture. Tissues were removed, weighed and 
frozen in liquid nitrogen. The tissues were then stored at -80°C. Blood 
was centrifuged at 3000 g for 20 min, separated into serum and plasma 
and stored at -80°C until analysis. Both right and left tibias and femurs 
were excised, cleaned of adhering soft tissue, wrapped in saline soaked 
gauze and stored at -20°C until mechanical tests were performed. 
Biochemistry 
At birth and d28 serum biochemistry was measured in all offspring 
using samples obtained from the saphenous vein or cardiac puncture (if 
pups were culled). Serum 25(OH)D was measured using enzyme-
immunoassay (ELISA) (Ref AC-57fl, Lot 59031, Immunodiagnostic 
Systems Limited, Boldon UK). This assay is specific for vitamin D3 and 
also measures vitamin D2, having 70% cross reactivity. The inter assay 
variation for the low and high controls was < 10%. 
Osteocalcin concentration was measured to reflect osteoblast 
activity using ELISA (Ref 8002, Lot 903875, Quidel Corporation, San 
Diego CA). This assay has been validated for use in guinea pig samples 
(74). The interassay variation of the high and low controls was < 10% 
with a 1:40 dilution of serum used. 
Deoxypyridinoline (DPD) concentration was measured to reflect 
osteoclast activity in serum using an ELISA (Ref 8032, Lot 903718, 
Quidel Corporation, San Diego CA). The interassay variation of the high 
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and low controls was < 10%. According to manufacturers specifications 
the antibody used in this assay cross-reacts with guinea pig samples. 
Bone Strength 
Bones stored at -20°C were thawed to room temperature (23°C) 
according to standard methods (64) and kept moist in saline soaked gauze 
(88). Right femur length, and the widths of the mid-diaphysis, knee, 
femoral head and neck as well as tibial length and mid-diaphysis width 
were measured using an electronic calliper (Control Company, 
Friendswood, Texas, USA) and the average of three measurements was 
taken. A test speed of 1 mm/min and a support span of 10 to 20 mm were 
employed with one loading point applying pressure to the bone. The 
fulcrum span was wider for the tibias than the femurs as well for the 
different time points but was maintained consistent across the samples 
within each bone type: birth femurs 10 mm, birth tibias 16 mm, d28 
femurs 14 mm, and d28 tibias 20 mm. Load was applied at a constant 
displacement rate in the anterior-posterior direction, midway between the 
two fixed supports on which the bone was mounted. Bones were loaded to 
failure. Upon failure measurements were taken on the width of cortical 
defined as the distance from the exterior (periosteum) to the interior of the 
dense surface wall of the bone (endosteum) and cancellous bone defined 
as the canal width of the canal separating the opposite ends of the 
endosteum. These were measured using an electronic calliper (Control 
Company, Friendswood, Texas, USA) and the average of three 
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defined as the distance from the exterior (periosteum) to the interior of the 
dense surface wall of the bone (endosteum) and cancellous bone defined 
as the canal width of the canal separating the opposite ends of the 
endosteum. These were measured using an electronic calliper (Control 
~. Company, Friendswood, Texas, USA) and the average ofthree 
measurements was taken. Data was obtained on the load at yield, flexure 
load at yield, Young's Modulus, maximum flexure strain, maximum load, 
flexure load at maximum load flexure extension at maximum load, flexure 
strain at maximum load, flexure stress at maximum load and flexure stress 
at 50% of break (flexure extension). 
3.4 Statistical Analysis 
Data were analyzed for main effects of the gestational diets, 
postnatal supplementation, gender and time as well as interaction effects 
using factorial ANOVA (SAS Inst., Inc, Cary, NC. 9.1, 2003). Post-hoc 
testing was conducted for interaction effects using Bonferroni's multiple 
comparison test. Data were expressed as mean ± standard deviation was 
normally distributed. Differences were considered significant if P<0.05. 
Although gender and time were tested as a main effects they were only 
explored further when they interacted with maternal diet or postnatal 
supplement. 
The estimated sample size required for this study was somewhat 
uncertain since no study has examined vitamin D status at birth and 
subsequent bone mass using the guinea pig. However, studies examining 
vitamin D deficiency in utero (46) or vitamin C (ascorbic acid) from 
weaning to aging (87) have used 8 to 10 per group. The primary outcome 
in this study was bone mass (at birth and weaning) assessed using BMC 
and BMD. It was assumed that a 10% reduction in bone mass is 
considered consistent with fracture and weak bones. Regional differences 
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have previously not been investigated using the guinea pig model. 
Precision of DXA is very good at 1-2% in small pups and <1% in larger 
rodents using the 45 00A DXA (60). Therefore, the estimated size effect 
(10%) for reduced BMC for this study exceeds the error of measurement 
(1% maximum). The sample size used in this study (20 sows/diet group) 
with 2 pups per litter would yield 40 pups per maternal diet group at birth 
and 20 pups for each of the postnatal supplementation groups. A sample 
of greater than 20 per group was achieved and provided a power greater 
than beta=0.90 with alpha=0.01. 
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3.5 Results 
Maternal Vitamin D Status 
Thirty-eight of the forty sows were successfully mated and delivered 
healthy litters, as shown in Figure 3-1. Litter size was not different between 
maternal diet groups (control 2.6 ± 0.8 vs. deficient 2.9 ±0.1, P=0.1815). One pup 
in the control group and two in the deficient group died at birth. In total 110 
offspring were born and 104 were studied (Figure 3-1). 
Two sows randomized to the vitamin D deficient group were removed 
from the study. One sow was removed due to complications during pregnancy and 
the other because of unsuccessful mating. There was no significant difference in 
the serum 25(OH)D of the sows before mating (at baseline), but, by day 42 of 
pregnancy sows in the deficient group had significantly lower 25(OH)D (Figure 
3-2). This statistically significant difference remained throughout pregnancy to 
delivery as well as to the end of lactation at 28 d postpartum. 
Neonatal Guinea Pigs 
Vitamin D status of the pups at birth was indicated by 25(OH)D. Main 
effects were present for diet and time, 25(OH)D was significantly lower in the 
deficient group compared to control (21.0 ± 38.6 vs. 56.1 ± 27.5 nmol/L, 
P<0.0002). There was also a significant difference between vitamin D status of 
the pups at birth versus d28 (Table 3-2). Both male and female offspring from the 
deficient diet group plus placebo supplement had lower 25(OH)D at d28 
compared to the male and female offspring from the control diet plus placebo and 
control diet plus supplement groups. Interaction effects between gender and 
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supplement were present; in the males, the 25(OH)D at d28 in the deficient diet 
group plus supplement was only significantly lower than control offspring 
(Figure 3-3). 
Weight of the pups was lower in the vitamin D deficient group at birth 
(169.6 ± 97.9 vs. 155.3 ± 97.9 g, P=0.042), and d28 (279.1 ± 47.4 vs. 255.9 ± 
44.2 g, P=0.024) (Figure 3-4). The postnatal supplement however did not alter 
weight or interact with time (P>0.05) and gender (P>0.05). There was no 
significant difference in the body length of the pups regardless of maternal diet or 
postnatal supplement (Table 3-3). 
Bone Mass 
Main effects of the maternal diet showed vitamin D deficient offspring 
had 6% lower whole body BMC (5.58 ± 2.69 g vs. 5.24 ± 2.52 g, P=0.012) 
(Figure 3-5A) regardless of time and gender as well as a 6.7% lower right tibia 
BMC (0.15 ± 0.07 vs. 0.14 ± 0.07 g, P=0.012) (Figure 3-5B) than the control 
group. As shown in Table 3-4 there were no other significant differences 
amongst the groups. Interaction effects between maternal diet and postnatal 
supplementation showed that the deficient group was lower than the control group 
in whole body BMD (P=0.045) unless they received supplemental vitamin D. 
Right and left femur BMC was lower at d28 in the deficient males unless they 
received the supplement (P=0.012) (Figure 3-6) of the right femur BMC. No 
main effects or interactions amongst diet, supplement, time or gender were 
present between the 4 groups in the BMC, BMD or area of the spine (Table 3-5) 
in vivo or of the tibias (Table 3-6) or femurs (Table 3-7). There was also no 
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present bet een the 4 groups in the ,  or area f the spine ( able 3-5) 
in vivo or of the tibias (Table 3-6) or fe urs (Table 3-7). There as also no 
significant difference between the tibias and femurs when scanned ex vivo when 
compared at birth or d28 (data not shown). 
Bone Biomarkers 
There was a significant difference in serum osteocalcin concentration of 
the pups at birth (P<0.01) with greater values in the control group than the 
deficient group (70.3 ± 12.6 vs. 66.4 ± 7.0 nmol/L) (Figure 3-7). There were no 
statistically significant differences amongst the groups due to the placebo or 
supplement (P=0.70), or interaction between gestational diet and postnatal 
supplement (P=0.095). As expected there was a significant difference in the 
osteocalcin values at birth and d28. A main effect of time was present with serum 
DPD concentration being significantly different at birth than at d28 (P=0.0075). 
Vitamin D supplementation did not have an effect on the DPD concentrations by 
weaning (Table 3-2). 
Mechanical Testing 
There was no difference in the size and shape of the bones as determined 
through measurement of the femoral length, head, neck, mid-diaphysis, knee, and 
femur cortical and cancellous (data not shown). Tibia length, mid-diaphysis 
cortical and cancellous measurements were taken and none were found to be 
statistically significant (data not shown). No main effects of gestational diet or 
post-natal supplement were significant in the femur load at yield, flexure load at 
yield, maximum flexure strain, maximum load, flexure load at maximum load, 
and flexure extension at maximum load at birth and d28 (Table 3-8 and 3-9). 
Main effects of supplementation were present for the femur Young's modulus 
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between the supplement and placebo groups regardless of gestational diet (Table 
3-9). Interaction effects showed flexure strain at maximum load and flexure stress 
at maximum load were significantly different amongst the treatment groups. 
No main effects were found due to maternal diet or post-natal 
supplementation at birth or d28 in the tibia maximum flexure strain, flexure load 
at maximum load, flexure extension at maximum load flexure strain at maximum 
load and flexure stress at maximum load. Significant main effects due to the 
gestational diets were observed in the tibia load at yield zero, flexure load at yield 
zero, the Young's modulus, and the maximum load (Table 3-10 and 3-11). 
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Table 3-2: Serum 25-hydroxyvitamin D, osteocalcin and deoxypyridinoline concentrations of guinea pigs grouped by gestational diet 
and supplement received after birth at birth and day 28 of study. 
Measurement 
25(OH)D 
(nmol/L) 
Osteocalcin 
(nmol/L) 
DPD 
(nmol/L) 
Time 
point 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Control Diet 
Placebo 
(n=24/24)2 
56.8 ± 24.6 
114.1 ±60.5 
70.7 ± 14.0a 
64.3±10.3A 
23.0 ± 15.3 A 
13.9 ± 10.3 B 
Supplement 
(n=31/25) 
55.5 ± 9.9 
118.9 ±42.9 
70.1±11.3a 
68.6 ± 9.8A 
21.6± 4.1 A 
19.7 ± 7.6 A 
Deficient Diet 
Placebo 
(n=23/20) 
16.4 ±10.3 
16.6 ±20.1 
67.0 ± 8.4b 
62.9 ± 7.9A 
21.9±8.6A 
22.1±8.9A 
Supplement 
(n=30/23) 
24.7 ±50.1 
47.8 ±55.0 
65.8 ± 5.2b 
66.2 ± 9.2A 
23.2 ± 7.8 A 
12.5 ± 8.9 B 
P-Values for Main Effect1 
Diet 
0.00013 
0.04 
0.49 
Supplement 
0.10 
0.70 
0.66 
Sex 
0.12 
0.20 
0.59 
Time 
0.0001 
0.07 
0.0001 
Data are mean ± SD. DPD: deoxypyridinoline. 
1
 P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. Values with different upper case superscripts indicate differences between 2 time-points. 
Sample sizes are for birth followed by d28. Sample was reduced to accommodate tissue sampling. 
An interaction among diet, supplementation, gender and time (P= 0.045) was observed, thus post-hoc testing not shown here. 
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Table 3-3. Size of guinea pigs at birth and day 28 by study group. 
Measurement 
Weight (g) 
Length (cm) 
Time 
point 
Birth 
Day 28 
Birth 
Day 28 
Control Diet 
Placebo 
(n=24/24)2 
109.7 ±2.1"* 
319.9 ±61.8aB 
15.4±1.0A 
22.3±1.5B 
Supplement 
(n=31/25) 
105.0 ±19.1"* 
312.3 ±48 .3^ 
15.3±0.9A 
22.4±1.1B 
Deficient Diet 
Placebo 
(n=23/20) 
97.5±17.7bA 
293.9 ± 56.9bB 
14.7±0.8A 
21.8±1.2B 
Supplement 
(n=30/23) 
100.6 ±18.6bA 
304.2±51.2bB 
15.0 ± 1.1 A 
22.3 ± 1.3 B 
P-Values for Main Effect1 
Diet 
0.03 
0.20 
Supplement 
0.87 
0.42 
Sex 
0.11 
0.21 
Time 
0.0001 
0.0001 
Data are mean ± SD 
P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. Values with different upper case superscripts indicate differences between 2 time-points. 
Sample sizes are for birth followed by d28. Sample was reduced to accommodate tissue sampling. 
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Table 3-4. Whole body bone mass of guinea pigs by gestational diet and supplement received after birth at birth and day 28 of study. 
Measurement 
Bone Area 
(cm2) 
BMC (g) 
BMD (g/cm2) 
Time 
point 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Control Diet 
Placebo 
(n=24/24)2 
28.32 ± 4.19A 
51.51 ±6.65B 
3.37 ± 0.67^ 
8.25 ± 1.55cB 
0.12±0.01A 
0.16±0.01B 
Supplement 
(n=31/25) 
27.49 ± 3.48 A 
51.04±5.89B 
3.18± 0 .58^ 
8.12 ± 1.27CB 
0.12±0.01A 
0.16±0.01B 
Deficient Diet 
Placebo 
(n=23/20) 
26.22 ± 2.85 A 
47.54 ± 5.89 B 
3.03 ± 0.49bA 
7.53 ± 1.39CB 
0.12±0.01A 
0.15±0.01B 
Supplement 
(n=30/23) 
26.98 ± 3.98 A 
49.84 ± 5.92 B 
3.18 ± 0.63 bA 
7.85 ± 1.33 CB 
0.12±0.01A 
0.16±0.01B 
P-Values for Main Effect1 
Diet 
0.06 
0.03 
0.343 
Suppleme 
nt 
0.49 
0.96 
0.84 
Sex 
0.25 
0.21 
0.13 
Time 
0.001 
0.001 
0.001 
Data are mean ± SD. BMC: bone mineral content; BMD: bone mineral density. 
1
 P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate differences 
between the 2 diet groups. Values with different upper case superscripts indicate differences between 2 time-points. 
2
 Sample sizes are for birth followed by d28. Sample was reduced to accommodate tissue sampling. 
An interaction among diet and supplement, gender and time was observed (0.045). 
u-. 
) ) ) 
1   r  
t 1 f
 t 
/ )2 
  A  A  A  
   6  ti .04  .  ti 13 13 
1 
.67 aA  .58 aA . 9 nA  nA  .  1 
.   . 5 ctl .   .  Cti .   .  Cti .   .  Cti 
" OI  2  O.OI  2  O.OI  2  0.  A 
 
 6  0. 13 ti 5  O.OI ti . 6  0.  tl 
------
  I I
1 - a1  t ria1  l. t differ  
r t s 
2 1 1  
3 
) 
Table 3-5. Spine bone mass of guinea pigs by gestational diet and supplement received after birth at birth and day 28 of study. 
Measurement 
Bone Area 
(cm2) 
BMC (g) 
BMD (g/cm2) 
Time 
point 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Control 
Placebo 
(n=24/24)2 
0.74 ± 0.11A 
1.38±0.13B 
0.12 ± 0 . 0 3 ^ 
0.23 ± 0.04B 
0.16 ±0.03 
0.17 ±0.02 
Supplement 
(n=31/25) 
0.75±0.14A 
1.42±0.14B 
0.12 ±0 .03^ 
0.24 ± 0.04B 
0.16 ±0.2 
0.16 ±0.02 
Deficient 
Placebo 
(n=23/20) 
0.69 ± 0.07A 
1.35±0.13B 
0.12±0.02bA 
0.21±0.04B 
0.17 ±0.02 
0.16 ±0.02 
Supplement 
(n=30/23) 
0.70 ± 0.08 A 
1.38 ± 0.28 B 
0.12±0.02bA 
0.27 ± 0.02 u 
0.16 ±0.02 
0.16 ±0.01 
P-Values for Main Effect1 
Diet 
0.06 
0.12 
0.50 
Supplement 
0.15 
0.10 
0.92 
Sex 
0.24 
0.08 
0.36 
Time 
0.001 
0.001 
0.57 
Data are mean ± SD. BMC: bone mineral content; BMD: bone mineral density. 
P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. Values with different upper case superscripts indicate differences between 2 time-points. 
Sample sizes are for birth followed by d28. Sample was reduced to accommodate tissue sampling. 
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Table 3-6. Tibia bone mass of guinea pigs by gestational diet and supplement received after birth at birth and day 28 of study. 
Measurement 
Right Tibia 
Area (cm2) 
Right Tibia 
BMC (g) 
Right Tibia 
BMD(g/cm2) 
Left Tibia 
Area (cm2) 
Left Tibia 
BMC (g) 
Left Tibia 
BMD(g/cm2) 
Time 
point 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Control 
Placebo 
(n=24/24)2 
0.88±0.10A 
1.3±0.10B 
0.80 ±0 .03^ 
0.19±0.04B 
0.09 ± 0.02A 
0.15±0.02B 
0.09 ± 0.03A 
1.33±0.14B 
0.09 ± 0.03^ 
0.22 ± 0.04B 
0.09 ± 0.02A 
0.16±0.02B 
Supplement 
(n=31/25) 
0.84±0.13A 
1.3±0.10b 
0.08 ± 0.04^ 
0.19±0.05B 
0.09 ± 0.02A 
0.14±0.03B 
0.09 ± 0.02A 
1.34±0.13B 
0.09 ± 0.02^ 
0.22±0.04B 
0.19±0.05A 
0.16±0.02B 
Deficient 
Placebo 
(n=23/20) 
0.80 ± 0.10A 
1.30±0.10B 
0.07±0.01bA 
0.17±0.05B 
0.09 ± 0.02A 
0.1 3±0.03b 
0.08 ± 0.03 A 
1.30±0.14B 
0.08 ± 0.03bA 
0.20 ± 0.04B 
0.09 ± 0.02A 
0.15±0.02B 
Supplement 
(n=30/23) 
0.78±0.10A 
1.3 ± 0.20 B 
0.07 ± 0.03bA 
0.19±0.04B 
0.11±0.2A 
0.14±0.02B 
0.09 ± 0.02 A 
1.28 ±0.17B 
0.09 ± 0.02bA 
0.19±0.04B 
0.09 ± 0.02A 
0.15±0.02B 
P-Values for Main Effect1 
Diet 
0.07 
0.02 
0.97 
0.09 
0.01 
0.25 
Supplement 
0.45 
0.26 
0.22 
0.92 
0.39 
0.42 
Sex 
0.06 
0.06 
0.12 
0.81 
0.07 
0.72 
Time 
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
Data are mean ± SD. BMC: bone mineral content; BMD: bone mineral density. 
P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. Values with different upper case superscripts indicate differences between 2 time-points. 
2
 Sample sizes are for birth followed by d28. Sample was reduced to accommodate tissue sampling. 
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Table 3-7. Femur bone mass of guinea pigs by gestational diet and supplement received after birth at birth and day 28 of study. 
Measurement 
Right Femur 
Area (cm2) 
Right Femur 
BMC (g) 
Right Femur 
BMD(g/cm2) 
Left Femur 
Area (cm2) 
Left Femur 
BMC (g) 
Left Femur 
BMD(g/cm2) 
Time 
point 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Birth 
Day 28 
Control 
Placebo 
(n=24/24)2 
0.77 ± 0.08A 
1.09±0.12B 
0.09 ± 0.03A 
0.29 ± 0.06B 
0.12±0.03A 
0.27 ± 0.06B 
0.76 ± 0.09A 
1.08±0.11B 
0.09±0.03A 
0.32 ± 0.07B 
0.14±0.03A 
0.29 ± 0.06B 
Supplement 
(n=31/25) 
0.73 ± 0.10 A 
1.09 ± 0.1 B 
0.09 ± 0.03 A 
0.29 ± 0.07 B 
0.12 ± 0.03 A 
0.27 ± 0.06 B 
0.75 ± 0.09 A 
1.09±0.10B 
0.09 ± 0.03 A 
0.32 ± 0.05 B 
0.12 ± 0.03 A 
0.29 ± 0.04 B 
Deficient 
Placebo 
(n=23/20) 
0.69 ± 0.08A 
1.02±0.14B 
0.08 ± 0.03A 
0.27 ± 0.08 B 
0.12±0.04A 
0.26 ± 0.05 B 
0.70 ± 0.07A 
0.97±0.18B 
0.08 ± 0.03 A 
0.28 ± 0.04 B 
0.13±0.03A 
0.28 ± 0.03 B 
Supplement 
(n=30/23) 
0.70 ± 0.08A 
1.07±0.10B 
0.09±0.03A 
0.30 ± 0.06 B 
0.13±0.3 A 
0.24 ± 0.05 B 
0.69±0.14A 
1.07±0.10B 
0.09 ± 0.03 A 
0.31 ± 0.06 B 
0.14±0.04A 
0.29 ± 0.04 B 
P-Values for Main Effect1 
Diet 
0.15 
0.243 
0.98 
0.06 
0.363 
0.53 
Supplement 
0.59 
0.28 
0.58 
0.12 
0.58 
0.52 
Sex 
0.54 
0.00 
3 
0.01 
0.33 
0.02 
0.40 
Time 
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
Data are mean ± SD. BMC: bone mineral content; BMD: bone mineral density. 
1
 P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. Values with different upper case superscripts indicate differences between 2 time-points. 
Sample sizes are for birth followed by d28. Sample was reduced to accommodate tissue sampling. 
An interaction among diet, supplementation, gender and time was observed (P=0.012). 
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Table 3-8. Biomechanical testing of right guinea pig femurs by gestational diet at birth. 
Measurement 
Load at yield (N) 
Flexure load at yield (kgf) 
Young's modulus (MPa) 
Maximum flexure strain (mm/mm) 
Maximum load (N) 
Flexure load at maximum load (kgf) 
Flexure extension at maximum load (mm) 
Flexure strain at maximum load (mm/mm) 
Flexure stress at maximum load (MPa) 
Control (n=6) 
-23.81 ± 5.67 
2.28 ± 0.67 
659.13 ±211.89 
0.18 ±0.04 
-0.15±0.03a 
0.02 ± 0.03 
0.43 ± 0.52 
0.06 ± 0.08 
0.13 ±0.43 
Deficient (n=6) 
-21.3 ±4.58 
2.17 ±0.47 
867.74 ±278.14 
0.24 ± 0.07 
-0.38 ± 0.26" 
0.04 ± 0.03 
0.16 ±0.48 
0.02 ± 0.06 
0.66 ± 0.48 
Main Effect Diet1 
0.62 
0.68 
0.39 
0.07 
0.02 
0.16 
0.76 
0.73 
0.11 
Data are mean ± SD. 
P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. 
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Table 3-9. Biomechanical testing of right guinea pig femurs by gestational diet and supplement received after birth at day 28 of 
study. 
Measurement 
Load at yield (N) 
Flexure load at yield 
(kgf) 
Young's modulus (MPa) 
Maximum flexure strain 
(mm/mm) 
Maximum load (N) 
Flexure load at maximum 
load (kgf) 
Flexure extension at 
maximum load (mm) 
Flexure strain at 
maximum load (mm/mm) 
Flexure stress at 
maximum load (MPa) 
Control Placebo 
(n=4) 
-31.92±21.17 
3.26 ±2.16 
665.70 ± 222.00 
0.12 ±0.02 
-0.50 ± 0.45 
0.05 ± 0.05 
-0.10 ±0.11 
-0.02 ± 0.02 
0.57 ± 0.63 
Control Supplement 
(n=4) 
-23.95 ± 26.87 
2.44 ± 2.74 
318.12 ±175.94 
0.17 ±0.03 
-0.24 ±0.01 
0.02 ± 0.01 
-0.05 ± 0.08 
-0.01 ±0.01 
0.17 ±0.05 
Deficient Placebo 
(n=6) 
-26.23 ±21.30 
2.67 ±2.17 
536.73 ± 270.75 
0.21 ±0.08 
-0.34 ± 0.27 
0.03 ± 0.03 
-0.09 ± 0.07 
0.044 ±0.01 
0.38 ±0.23 
Deficient Supplement 
(n=5) 
-20.56 ±27.12 
2.10 ±2.77 
357.24 ±170.70 
0.16 ±0.04 
-0.48 ±0.36 
0.05 ± 0.04 
0.29 ± 0.07 
-0.18 ±0.01 
0.40 ±0.21 
Main Effect 
Supplement1 
0.45 
0.45 
0.09 
0.99 
0.67 
0.67 
0.42 
0.40 
0.45 
Data are mean ± SD. 
1
 P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate differences 
between the 2 diet groups. 
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Table 3-10. Biomechanical testing of right guinea pig tibias by gestational diet at birth. 
Measurement 
Load at yield (N) 
Flexure load at yield (kgf) 
Young's modulus (MPa) 
Maximum flexure strain (mm/mm) 
Maximum load (N) 
Flexure load at maximum load (kgf) 
Flexure extension at maximum load 
(mm) 
Flexure strain at maximum load 
(mm/mm) 
Flexure stress at maximum load (MPa) 
Control (n=6) 
-24.39 ± 4.97a 
2.48 ± 0.50a 
1502.70 ± 467.76 a 
0.17=1=0.12 
-0.67 ±0.40 
0.07 ± 0.04 
0.88 ±1.07 
0.12±0.16 
1.7±1.14 
Deficient (n=6) 
-16.81 ±3.49" 
1.71 ±0.36" 
957.99 ±149.02" 
0.20 ±0.16 
-0.46 ±0.17 
0.05 ± 0.02 
1.20 ± 1.44 
0.15 ±0.19 
1.43 ±0.62 
Main Effect Diet1 
0.007 
0.01 
0.0005 
0.95 
0.32 
0.32 
0.52 
0.62 
0.34 
Data are mean ± SD. 
1
 P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case superscripts indicate 
differences between the 2 diet groups. 
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Table 3-11. Biomechanical testing of right guinea pig tibias by gestational diet and supplement received after birth at day 28 of 
study. 
Measurement 
Load at yield (N) 
Flexure load at yield (kgf) 
Young's modulus (MPa) 
Maximum flexure strain 
(mm/mm) 
Maximum load (N) 
Flexure load at maximum 
load (kgf) 
Flexure extension at 
maximum load (mm) 
Flexure strain at maximum 
load (mm/mm) 
Flexure stress at maximum 
load (MPa) 
Control Placebo 
(n=4) 
-43.11 ±11.88 
4.13 ±1.38 
849.15 ±22.47 
0.27 ±0.13 
-0.82 ± 0.40 
0.08 ± 0.04 
0.54 ±1.09 
0.08 ± 0.2 
1.16 ±0.45 
Control Supplement 
(n=4) 
-48.42 ± 7.07 
4.93 ± 0.72 
982.00 ± 77.03 
0.24 ± 0.06 
-0.80 ±0.36 
0.08 ± 0.04 
-0.001 ±0.001 
-0.001 ± 0.01 
1.10 ±0.44 
Deficient Placebo 
(n=6) 
-38.61 ± 7.07 
3.94 ±0.72 
803.24 ±177.35 
0.26 ±0.14 
-0.71 ±0.33 
0.07 ± 0.03 
0.29 ± 0.07 
0.06 ±0.1 
1.02 ±0.44 
Deficient Supplement 
(n=5) 
-36.19 ±11.74 
3.69 ±1.20 
660.20 ±128.14 
0.2 ± 0.09 
-0.40 ± 1.49 
0.04 ±0.15 
0.33 ± 0.07 
0.05 ±0.0.1 
0.40 ±2.11 
Main Effect 
Supplement1 
0.70 
0.49 
0.96 
0,45 
0.62 
0.49 
0.49 
0.96 
0.45 
Data are mean ± SD. P-values reflect main effects identified in a factorial ANOVA model. Values with different lower case 
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Figure 3-1. Study Design and Sample Size. 
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Figure 3-2. Sows serum 25(OH)D through pregnancy and lactation. 
Sample sizes were; control n=20, deficient n=18. Values with different 
superscripts indicate P<0.05 using post-hoc testing with Bonferroni's multiple 
comparison test. Interaction between diet and time (P=0.034) Data are mean ± 
SD. 
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Figure 3-3. Serum 25(OH)D at d28 in male and female offspring. Sample sizes at 
day 28 were: control placebo male (n=10), control placebo female (n=14), control 
supplement males (n=13), control supplement females (n=12), deficient placebo 
male (n=13), deficient placebo female (n=7), deficient supplement male (n=l 1), 
deficient supplement female (n=12). Interaction between postnatal supplement, 
gender and time (P=0.0002). Values from post-hoc testing with different 
superscripts indicate PO.05 using post-hoc testing with Bonferroni's multiple 
comparison test. Data at birth not shown. Data are mean ± SD. 
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Figure 3-4. Body weight of offspring according to maternal diet during 
pregnancy and lactation. Sample sizes at birth and day 28 were: control 
(n=55,49), deficient (n=53,43). Main effect of maternal diet P=0.03. Values with 
different superscripts indicate PO.05 using post-hoc testing with Bonferroni's 
multiple comparison test. Data are mean ± SD. 
62 
 
_Control ~Defic ent
c 
300 d 
- a C) b 
-.... 
.s:: 
C) 200 
.-Q) 
3: 
100 
o 
irt  
 i  i
t t  i O . 
t <O.0 f
Control Birth Deficient Birth 
Figure 3-5A. Whole body (A) and right tibia (B) bone mineral content (BMC) at 
birth. In offspring from control (n=55) and deficient (n=53) groups. Main effects 
of gestational diet on whole body BMC (P=0.012) and right tibia (P=0.02). 
Values with different superscripts indicate P<0.05 using post-hoc testing with 
Bonferroni's multiple comparison test. Data are mean ± SD. 
63 
.r-\ 
10 
A 
-C) a 
- b 0 8 
:E 
al 
~ 6 
"0 
0 
al 
Q) 4 
ë5 
J: 2 ~ 
0 
0.3 B 
-C) 
-0 a b 
:lE 
al 0.2 
ca 
.-
.0 
i= 
+" 0.1 J: 
C) 
il: 
0.0 
l i  fi i t i t  
I  
i  t ef
gest O. O
t O  
'  
 
0.4-
3 
o 
m 
0.3-
E 0.2-
<D 
0 ) 0 . 1 
£ 
0.0-
H^3 Control Placebo ™ Deficient Placebo 
11 Control Supplement • Deficien Supplement 
£ b 
< Males > <—Females—> 
Figure 3-6. Right femur bone mineral content (BMC) of offspring at day 28 
according to treatment and gender. Sample sizes day 28 was: control placebo 
male (n=10), control placebo female (n=14), control supplement males (n=13), 
control supplement females (n=12), deficient placebo male (n=13), deficient 
placebo female (n=7), deficient supplement male (n=l 1), deficient supplement 
female (n=12). Interaction between postnatal supplement and gender (P=0.012). 
Values from post-hoc testing with different superscripts indicate P<0.05 using 
post-hoc testing with Bonferroni's multiple comparison test. Data are mean ± SD. 
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Figure 3-7. Serum osteocalcin in offspring at birth according to maternal diet, in 
offspring from control (n=55) and deficient (n=53) groups. Main effect of 
gestational diet (P=0.04). Values with different superscripts indicate P<0.05 using 
post-hoc testing with Bonferroni's multiple comparison test. Data are mean ± SD. 
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3.6 Discussion 
While vitamin D deficiency can be reversed in human infants through 
supplementation (89), it is unclear if the long-term sequelae of deficiency in utero 
manifests as altered bone mass and metabolism. The objective of this study was to 
establish whether maternal dietary vitamin D deficiency in pregnancy has a 
negative impact on fetal mineralization and if postnatal supplementation in the 
offspring would normalize bone mass using a guinea pig model. The induction of 
dietary deficiency at mating yielded significant reductions in maternal serum 
25(OH)D throughout pregnancy and resulted in offspring with vitamin D 
deficiency at birth defined as < 27.5 nmol/L (15). Thus the model was successful 
at inducing both maternal and neonatal vitamin D deficiency. The two 
hypotheses tested were, that offspring born to vitamin D deficient mothers will 
have lower vitamin D status at birth and require post natal vitamin D 
supplementation to normalize vitamin D stores. As well as have decreased bone 
mass and strength unless vitamin D supplementation is provided. These 
hypotheses were accepted based on the results presented above. 
This is the first study to investigate the effect of vitamin D deficiency on 
bone mass of guinea pigs at full term birth and at weaning. Like the studies by 
Rummens et al. (46,74) and Verhaeghe et al. (46,74) that investigated maternal 
and fetal guinea pig vitamin D status at birth, this study also found the vitamin D 
concentrations of the pups were comparable to that of a human fetus (46,74). 
Vitamin D concentrations in the pups increased between birth and weaning, but 
males from the deficient group who received the postnatal supplement failed to 
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achieve normal concentrations, whereas the females in the same group reached 
values comparable to control. This suggests that females are able to mount a 
higher 25(OH)D than males in response to vitamin D supplementation. 
Alternatively males may require a larger dose of supplement in order to increase 
their vitamin D status. This is the first time the effectiveness of vitamin D 
supplementation and subsequent recovery have been investigated controlling for 
gender. None of the vitamin D deficient groups however reached the suggested 
optimal serum vitamin D levels over 75 nmol/L (90), whereas those in the control 
group on average had values over 75 nmol/L regardless of postnatal 
supplementation. 
The low birth weight of the vitamin D deficient pups which was carried 
through weaning, suggests that a vitamin D deficiency may indirectly play a role 
in reduced bone mass. In humans, birth weight and weight at one year have been 
shown to be independent determinants of bone mass seven decades later (91). The 
differences in guinea pig weights at weaning age suggest that the intra uterine 
environment may have a far reaching effect on neonatal development, providing 
further evidence for the theory of fetal programming. 
Maternal vitamin D deficiency reduces whole body BMC in offspring who 
were removed by laparotomy on day 57 of gestation (46). In the present study a 
maternal vitamin D deficiency reduced whole body BMC in offspring who were 
carried to term. This has also been noted in human infants, where relative to body 
weight whole body BMC was found to be lower in infants of vitamin D deficient 
mothers (35). The significance of the effect of maternal vitamin D deficiency was 
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demonstrated by Javaid et al, (40) who documented a lower maternal vitamin D 
status during late pregnancy was associated with lower whole body and lumbar 
spine BMC in the offspring at 9 years of age (40). Supplementation at birth has 
been shown to increase BMD at appendicular skeletal sites at 8 years of age (81). 
The guinea pig data also suggests that long bones are affected by an intra uterine 
deficiency of vitamin D. Both the tibia and femur demonstrated reduced bone 
mass. Since these bones are at risk of fracture later in life, optimization of mineral 
content in childhood is crucial to increase quality and longevity of life. 
Fortunately, interaction effects revealed that postnatal vitamin D supplementation 
normalized neonatal whole body BMD and femur BMC following maternal 
dietary vitamin D deficiency in the guinea pig. 
Both osteocalcin and DPD were measured after birth and weaning. DPD 
has only been investigated in weanling male guinea pigs (92) and osteocalcin has 
been measured at day 63 of pregnancy in fetal guinea pigs (74,92). There were 
higher concentrations of osteocalcin in the pups who received the diet adequate in 
vitamin D. This suggests that there is a higher amount of bone formation in the 
pups that were vitamin D sufficient. This scenario also occurs in human infants 
with low 25(OH)D who have also been shown to have low osteocalcin levels (69). 
There was no difference in DPD values between the gestational diets suggesting 
that vitamin D deficiency in early life does not immediately accelerate bone 
resoption. This may be related to the postnatal period being a time of heightened 
bone turnover (12). The effects of an intra uterine vitamin D deficiency may be 
realised later in life once growth is complete. 
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here as no difference in P  values bet een the gestational diets suggesting 
that vita in  deficiency in early life does not i ediately accelerate bone 
resoption. his ay be related to the postnatal period being a ti e of heightened 
bone turnover (12). The effects of an intra uterine vita in  deficiency ay be 
realised later in life once growth is co plete. 
Biomechanical testing revealed that increased tibia bone strength was due 
to the maternal diet, which provided adequate vitamin D, with an increase in 
energy required to break the tibia through an increase in the Young's modulus, 
maximum load and the flexure load. The effect of supplementation on femoral 
Young's modulus was not expected with there being a higher Young's modulus in 
the pups who had received the placebo supplement (both deficient and control 
groups) over the two groups who received post natal supplementation. This could 
have been due to reduced mineralization in the bones of the non-supplemented 
group making it more flexible and more willing to bend before breaking. 
However, due to the small sample size available for biomechanical testing this 
could not be further investigated. There was also an increase in the amount of 
stress that could be put on the femurs of the deficient group at birth before failure; 
this too might have been related to lower mineral content. The elastic nature of 
bone in vitamin D deficiency manifests as bowed legs in human infants, thus the 
guinea pig model appears to be very reflective of the human scenario. 
There are many strengths of this novel study such as the large sample size, 
as well as biochemical and biomechanical analysis to the support the DXA 
analysis. The primary outcome in this study was bone mass (at birth and 
weaning) assessed using BMC and BMD. A sample size of greater than 20 per 
group was achieved and provided a power greater than beta=0.90 with 
alpha=0.01. This data was supported through biochemical analysis of bone 
markers and serum 25(OH)D measurements. In addition serum 25(OH)D 
concentrations were measured in the sows to confirm deficiency was present by 
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the third trimester of pregnancy when mineralization of bone takes place in the 
fetus. The DXA data was also supported by bone strength testing, this was 
important in determining if a decrease in BMC or BMD leads to reduced bone 
strength and subsequent fragility and risk of fracture. 
In human infants the cause of vitamin D deficiency is not always clear and 
can be present in association with other dietary deficiencies that may affect bone. 
Furthermore, the onset of deficiency during pregnancy is almost never known. 
While vitamin D deficiency can be reversed in human infants through 
supplementation, it is unclear if the consequences of deficiency in utero manifests 
as altered bone mass and metabolism at weaning age. Thus this thesis data more 
clearly suggests that postnatal vitamin D supplementation normalizes neonatal 
bone following maternal dietary vitamin D deficiency in the guinea pig. This 
information can be used to drive vitamin D intervention strategies in human 
pregnancy and infancy with eventual implications for public policy on vitamin D 
fortification and supplementation practices. 
Future studies are required to determine the optimal dose of vitamin D. 
Whether there are gender differences in the dosage and dosing schedule required 
for optimal bone development of males and females. Long-term studies are 
required to determine the consequences of intrauterine deficiency of vitamin D to 
bone mass across the lifespan. Also the role and requirement for vitamin D in pre-
term versus full-term gestational infants will have to be examined. 
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4.0 General Discussion 
This is the first study to determine if a vitamin D deficiency 
created in utero will have postnatal effects and if they can be corrected 
through vitamin D supplementation after birth. It was shown that a 
maternal diet deficient in vitamin D produced offspring who had lower 
whole body BMC and tibia BMC than the offspring of sows who were 
provided adequate vitamin D. Unless they received the supplemental 
vitamin D the deficient group was lower than the control group in whole 
body BMD and femur BMC. This data was supported through 
biochemical analysis of bone markers and serum vitamin D measurements. 
Vitamin D deficiency leads to decreased absorption of calcium 
from the small intestine (12). With reduced dietary calcium absorption 
bone calcium is dissolved in order to maintain adequate blood calcium 
levels for metabolic, signal transduction and neuromuscular activities (12). 
This mechanism may have lead to the reduced BMC in the vitamin D 
deficient pups. 
Growth supports an increase in vitamin D due to the increased 
requirement of calcium for bone development (12). The vitamin D 
deficient offspring weighted less that the offspring who received vitamin 
D suggesting that vitamin D may play a roll in subsequent growth. This 
may also have an effect on subsequent bone health since adult women 
born small size for gestational age have higher circulating l,25(OH)2D 
(24). 
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This model of vitamin D deficiency also yielded lower osteocalcin 
levels as is observed in human infants (74). The DXA data was also 
supported by bone strength testing using a materials testing machine. This 
was important in determining if a decrease in BMC or BMD leads to 
reduced bone strength and subsequent fragility and risk of fracture. Our 
sample size was adequate to detect differences in DXA measurements and 
biochemical tests amongst groups and genders. However our small sample 
size form the biomechanical tests may have limited our ability to fully 
assess the effect of maternal diet and postnatal supplementation on bone 
strength . The strengths of this study are that this is the first time that the 
effects of an intrauterine deficiency of vitamin D have been studied in full 
term pregnant guinea pigs who like humans mineralize in utero. Serum 
vitamin D concentrations confirmed that vitamin D deficiency was present 
by the third trimester of pregnancy when mineralization of bone takes 
place in guinea pigs. Further, in humans the maternal fetal transfer of 
25(OH)D seems to be regulated in that maternal values are higher than 
those of newborn offspring (35). The pups' vitamin D status was much 
lower than maternal vitamin D status further confirming that this is an 
appropriate model to study maternal vitamin D deficiency and the effects 
on fetal and newborn nutrition. It suggests that the maternal diet affects 
the status of their offspring. The mechanism of this is unclear and whether 
it is through placental regulation or another mechanism will need to be 
investigated. Maternal vitamin D status increased between delivery and 
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d28 this could be due to the mobilisation of fat stores which occurs during 
lactation (93). 
Another strength, yet potential limitation of the study, is that this is 
the first study to examine the effects of vitamin D deficiency and 
subsequent recovery of bone using the guinea pig model. Therefore the 
growth rate and development of the guinea pig especially in relation to 
bone were uncertain. As well, the amount of vitamin D in the guinea pig 
milk has yet to be determined and would have been advantageous to 
further validate the model as representative of the human scenario; i.e. low 
maternal milk vitamin D. Lastly, it would also have been advantageous to 
measure parathyroid hormone (PTH) because of its role in indirectly 
stimulating production of the active form of vitamin D in the kidney along 
with direct effects on bone metabolism. PTH and 25(OH)D levels are 
inversely related and often used to target optimal vitamin D status. There 
are currently no available assays for parathyroid PTH in the guinea pig. 
This is due in part to the fact that many assays are based on guinea pig 
antibodies to rat or human PTH and there is low demand for the product. 
The diets used in this study have been used successfully by others 
(46) and there is enough information to demonstrate that the guinea pig 
mimics the human intra uterine response to vitamin D deficiency that 
manifests as reduced bone mass. Delivery of the supplement was very 
feasible since guinea pig pups can be easily hand reared from birth and 
due to their chemical and physiological maturity supplementation was 
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easy to administer (75). The delivery was given orally as would be the 
case for human infants and the vehicle itself was the matrix from a human 
infant vitamin D supplement. The product itself was also manufactured, 
specifically for this study, by a company that manufactures infant 
supplements. Thus the diets and supplements were major strengths of the 
study. 
In retrospect a higher dosage of supplement could have resulted 
in stronger results for the male offspring. However, to have bone recovery 
after weaning with only a 10 IU supplement of vitamin D in the females, 
demonstrates the importance of vitamin D in bone health as well as the 
potential to reverse the negative affects manifested in utero. This has 
profound implications for health care and policy making suggesting that a 
mothers nutrient deficiency does not signify that her offspring has to 
suffer the potentially life threatening consequences associated with 
vitamin D deficiency. 
Although the supplement was adequate for maintenance of 
vitamin D status and bone recovery in the pups it was not adequate to 
optimize vitamin D status in the deficient group regardless of gender. 
Conversely, a higher dosage supplement would not be required if 
maternal vitamin D status had been optimal. In fact a lower dose 
supplement may have maintained optimal vitamin D since values in the 
control placebo group increased from birth to d28. In that case the 
postnatal supplement would be important in maintaining vitamin D status 
76 
 
 lf 
t lf f
ll    
r  
          
      . ,     
r  l    
 I
ts t   
  
 f  i  
r  
fi
  
t  
  
I
  
 . 
    
rather than correcting a vitamin D deficiency. This is the ideal case since 
maintenance of vitamin D status ensures optimal bone growth both in 
utero and after birth, where as postnatal correction of the deficiency 
means that there is a crucial period of time in which bone growth may not 
be optimised. 
The lower vitamin D status in the males who were deficient at 
birth and subsequently received vitamin D supplementation could be 
related to an increased need for production of muscle (93). Clements et al. 
(45) discovered that vitamin D was mostly stored in the muscle tissue of 
fetal rats. Although no difference was found in body composition between 
males and female offspring between birth and d28 vitamin D may have 
been stored for subsequent growth and development. 
In summary although the role of vitamin D in bone health and the 
prevention of rickets has been known since the late 1930's (12), and that 
vitamin D deficiency can be reversed in human infants through 
supplementation (35), it was unclear if the consequences of deficiency in 
utero manifest as altered bone mass and metabolism at weaning age. This 
thesis data suggests that postnatal vitamin D supplementation normalized 
neonatal bone following maternal dietary vitamin D deficiency in the 
guinea pig. 
Future studies are required to determine the optimal dose of vitamin 
D, and to investigate whether the deficiency in utero programmes for low 
peak bone mass. Whether there are gender differences in the dosage and 
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dosing schedule required for optimal bone development of males and 
females also requires investigation. Long term studies are required to 
determine the consequences of intrauterine deficiency of vitamin D to bone 
mass across the lifespan. As well, biomechanical testing in areas such as the 
lumbar spine, ulna and regions of the femur such as the femoral head 
should be examined. These are areas with areas with increased risk of 
fracture with age (12). 
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